Sign Up Today and Learn More About Atom Bioscience & Pharmaceutical Stock
Invest in or calculate the value of your shares in Atom Bioscience & Pharmaceutical or other pre-IPO companies through EquityZen's platform.
Atom Bioscience & Pharmaceutical Stock (ATBP)
Atom Bioscience is a clinical-stage biotechnology company.
About Atom Bioscience & Pharmaceutical Stock
Founded
2012
Industries
Software, Artificial Intelligence, Data and Analytics
Atom Bioscience & Pharmaceutical Press Mentions
Stay in the know about the latest news on Atom Bioscience & Pharmaceutical
Atom Therapeutics and China Medical System Holdings Enter Exclusive Commercialization Agreement for Lingdolinurad (ABP-671) to Treat Chronic Gout and Hyperuricemia
businesswire • Dec 03, 2024
IMIDAZO[1.2A]PYRIDINES FOR THE TREATMENT OR PREVENTION OF HYPERURACHEMIA OR …
patents • Apr 14, 2024
Solid forms of a compound for treating or preventing hyperuricemia or gout
patents • Apr 14, 2024
Atom Bioscience Receives FDA IND Clearance for Clinical Trial of ABP-745 for Acute Gout
finance • Mar 02, 2024
Atom Bioscience Receives FDA IND Clearance for Clinical Trial of ABP-745 for Acute Gout
businesswire • Feb 10, 2024
Atom Bioscience & Pharmaceutical Management
Leadership team at Atom Bioscience & Pharmaceutical
Chief Medical Officer
Marc Gurwith
CEO, President, Chairman, & Founder
William (Dongfang) Shi
Join now and verify your accreditation status to gain access to:
- Atom Bioscience & Pharmaceutical current valuation
- Atom Bioscience & Pharmaceutical stock price
- Available deals in Atom Bioscience & Pharmaceutical and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Atom Bioscience & Pharmaceutical stock?
Accredited investors can buy pre-IPO stock in companies like Atom Bioscience & Pharmaceutical through EquityZen funds. These investments are made available by existing Atom Bioscience & Pharmaceutical shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Atom Bioscience & Pharmaceutical stock?
Shareholders can sell their Atom Bioscience & Pharmaceutical stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
